These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16420518)

  • 41. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
    Tuncer I; Ozbek H; Ugras S; Bayram I
    Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of selective versus non-selective cyclooxygenase inhibitors on ischemia-reperfusion-induced hepatic injury in rats.
    Abdel-Gaber SA; Ibrahim MA; Amin EF; Ibrahim SA; Mohammed RK; Abdelrahman AM
    Life Sci; 2015 Aug; 134():42-8. PubMed ID: 26006041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
    Sun W; Gui S; Wu L; Wang H; Wei W
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A role for thrombin in liver fibrosis.
    Duplantier JG; Dubuisson L; Senant N; Freyburger G; Laurendeau I; Herbert JM; Desmoulière A; Rosenbaum J
    Gut; 2004 Nov; 53(11):1682-7. PubMed ID: 15479692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of the herbal medicine Gan‑fu‑kang against carbon tetrachloride‑induced liver fibrosis in rats.
    Zhang C; Wang Y; Chen H; Yang G; Wang S; Jiang M; Cong L; Yuan L; Li H; Jia Y
    Mol Med Rep; 2013 Sep; 8(3):954-62. PubMed ID: 23857550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
    Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
    Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4].
    Yang HX; Yi YR
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):919-25. PubMed ID: 19001734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
    Horrillo R; Planagumà A; González-Périz A; Ferré N; Titos E; Miquel R; López-Parra M; Masferrer JL; Arroyo V; Clària J
    J Pharmacol Exp Ther; 2007 Dec; 323(3):778-86. PubMed ID: 17766677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
    Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
    J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis.
    Bingül İ; Başaran-Küçükgergin C; Aydın AF; Çoban J; Doğan-Ekici I; Doğru-Abbasoğlu S; Uysal M
    Environ Toxicol Pharmacol; 2016 Jul; 45():170-8. PubMed ID: 27314760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-fibrotic effects of the Masson pine pollen aqueous extract on hepatic fibrosis rat model.
    Cong T; Jin XY; Zhao L; Ma L; Li RS; Zhao P; Guo CJ
    Int J Clin Exp Pathol; 2015; 8(5):4651-61. PubMed ID: 26191155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
    Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
    Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of TGF-β, PDGF, and CTGF in hepatic fibrosis models using DMN, CCl4, and TAA.
    Park HJ; Kim HG; Wang JH; Choi MK; Han JM; Lee JS; Son CG
    Drug Chem Toxicol; 2016; 39(1):111-8. PubMed ID: 26045230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats.
    Gao JH; Wen SL; Feng S; Yang WJ; Lu YY; Tong H; Liu R; Tang SH; Huang ZY; Tang YM; Yang JH; Xie HQ; Tang CW
    Angiogenesis; 2016 Oct; 19(4):501-11. PubMed ID: 27380212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery.
    Tasci I; Mas MR; Vural SA; Comert B; Alcigir G; Serdar M; Mas N; Isik AT; Ates Y
    Liver Int; 2006 Mar; 26(2):261-8. PubMed ID: 16448466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing.
    Simon AM; O'Connor JP
    J Bone Joint Surg Am; 2007 Mar; 89(3):500-11. PubMed ID: 17332098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats.
    Liu H; Zhang Z; Hu H; Zhang C; Niu M; Li R; Wang J; Bai Z; Xiao X
    BMC Complement Altern Med; 2018 Jul; 18(1):212. PubMed ID: 29986685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Shugan-Huayu powder, a traditional Chinese medicine, on hepatic fibrosis in rat model.
    Cheng CC; Lin NN; Lee YF; Wu LY; Hsu HP; Lee WJ; Tung KC; Chiun YT
    Chin J Physiol; 2010 Aug; 53(4):223-33. PubMed ID: 21793332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.